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tic endografl positioning using RMRI in animal model of AAA. 
Methods and Results. For rtMRl we used a clinical 1.5T MRI scanner customized with a 
rapid external image reconstruction system, in-lab consoles, phased-array surface coils, 
and interactive Interventional features such as independent channel coloring and gain, 
magnetization preparation, and interleaved multiplanar acquisition. Typical parameters 
using steady state free precession (“FISP’) were 258x128 matrix, 3/4 partial phase Fou- 
rier, flip angle 80”, field of view 3&m, and bandwidth * 82.5kH.z. Stable infrarenal 
abdominal aortic aneurysm was created in 50-70kg Yorkshire swine by transfemoral 1.8- 
2.0-fold balloon overstretch under rtMRI. Clinical intravascular 0.030” MRI guidewire 
recewer coils (lnterceptTM, Surgi-Vision) guided percutaneous device placement. Clinical 
tubular stent-grafts were positioned to exclude the AAA under simultaneous multiplanar 
rtMRl guidance. Conventional MRI and MRA demonstrated appropriate aneurysm exclu- 
sion. 
Conclusion. rtMRl successfully guides AAA endografl delivery in a pig model, and is a 
promising guidance modality for clinical procedures. Simple customization of endografts 
and delivery systems can be expected to facilitate accurate device placement in patients 
with complex aneurysm disease. 
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1100-199 Contrast Enhanced Duplex Ultrasound Improves 
Endoleak Detection Following Endovascular Abdominal 
Aortic Aneurysm Repair 
Andrew B. Civitellq Amy Woodruff, Hatim Mahmood, Kathy Doughtery. Cynthia Askins, 
Zvonimir Krajcer, Stephanie Coulter. Texas Heart Institute. Houston, TX 
Background: Development of blood flow outside the graft lumen (endoleak) may occur 
at any time after endoluminal AAA exclusion, exposing the patient to increased risk of 
aneurysm rupture. Patients must undergo lifelong surveillance imaging to ensure long 
term freedom from graft failure. The gold standard for endoleak detection, computed 
axial tomographic (CT) angiography, is expensive, inconvenient and exposes the patient 
to potentially nephrotoxic contrast. Duplex ultrasound (DU) is an attractive alternative, 
but concerns regarding accuracy have precluded its widespread clinical acceptance. 
Optison is an intravenous contrast agent used with echocardiography to enhanca 
endocardial border detection. We hypothesized that Optison enhancement of DU imag 
ing would improve the diagnostic accuracy for endoleak diagnosis. This study compares 
contrast enhanced DU with standard DU and CT angiography for the diagnosis of 
endoleaks after endovascular AAA repair. 
Methods: After endovascular AAA repair, 48 patients underwent follow-up imaging with 
CT angiography, DU and Optison enhanced DU at regular intervals. In 52 concurrent 
scan pairs, the accuracy of endoleak detection using DU with and without contrast 
enhancement was compared with CT angiography. 
Results: Unenhanced DU had a sensitivity of 57%, specificity of 94%, PPV of 80% and a 
NPV of 85%. Addition of Optison enhancement significantly improved the sensitivity, 
PPV and NPV. which were 87%, 67% and 95% respectively. Specificity remained 
unchanged at 94%. Both enhanced and unenhanced DU indicated endoleaks in 2 
patients, which were not detected by CT angiography. 
Conclusions: Contrast enhanced DU is more accurate than standard DU for the detec- 
tion of endoleaks following endovascular AAA repair and is a reliable screening test. The 
false positive results with contrast enhanced DU may be due to the failure of CT angiog- 
raphy to detect slow flow in collateral pathways. Although encouraging. further studies 
are needed in a larger group of patients to determine if contrast enhanced DU is reliable 
enough to replace CT angiography in routine follow-up after endovascular AAA repair. 
1100-200 Nanomanufactured Nltinol Self-Expanding Stent Graft 
in a Carotid System in a Porcine Model 
Steven R. Bailey, Eugene Sprague, Chris Boyle, Luis Velez, Jodie Polan, Julio Palmaz, 
University of Texas Health Sciences Center at San Antonio, San Antonio, TX 
Background: Current stent designs are limited by neo intimal proliferation and thrombo- 
sis. This process appears to be related to both the degree of vascular injury and the 
purity of the stent metals. We have previously reported the impact of metal impurities on 
in-vitro stent performance. This investigation is the first report of the in viva results of an 
ultra pure, nano synthesized self expanding stent graft. Materials and Methods: 
Nanomanufactured metal stent grafts, 5 pm thick, were developed using high vacuum 
sputtering techniques and attached onto proprietary designed nitinol stents. The stents 
were deployed in the carotid arteries of nine domestic swine (one in each carotid artery) 
with the distal carotid segments serving as controls. Three animals were sacrificed 
immediately after placement. The remaining six animals were sacrificed at 10 days and 
28 days. Patency, thrombus. and neointimal hyperplasia were evaluated using angiogra- 
phy, X-ray, and histopathological analysis 
Results: All stents were patent at the time of specified angiographic follow up. Complete 
endothelialization was seen at 10 days on the stent struts and the graft material. The 
injury scores were 0.28 at 10 days and 24 at 28 days. Neointimal hyperplasia was only 
180.7 * 82um at 10 days with minimal neointimal hyperplasia (221.2 * 108 urn) at 28 
days. The inflammatory score was also very low at both 10 and 26 days at 0.75. Conclu- 
sions: 1. Ultra pure self expanding nitionol stents result in less neointimal proliferation 
than that reported for other stent materials. 2. Prompt re-endothelialization occurs over 
the entire stent surface Including the 5 micrometer stent graft. 3. Limited injury is seen 
with this stent graft that distributes the stent expansion force over a larger surface area. 
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1101-173 High Versus Low Dose of Acetylcisteine to Prevent 
Contrast Agents Associated With Nephrotossicity 
Carlo Briauori Antonio Colombo, Anna Violante, Pasquale Balestrieri, Bruno Golia, 
Pierfranco Scarpato, PietroPaolo Elia, Stefano Lepore. Bruno Ricclardelli, Clinica 
Mediterrane, Naples, Italy, San Raffaele Hospital, Milan, Italy 
Background: In patients with chronic renal insufficiency, prophylactic oral administration 
of the antioxidant acetylcisteine, along with hydration, prevents the reduction in renal 
function induced by a small amount of non-ionic, low-osmolality contrast dye. We hypoth- 
esized that higher dose of acetylcisteine might be more effective with higher amount of 
contrast dye. 
Methods. From September 2001, 118 consecutive patients with impairment of renal func- 
tion, referred to our Institution for coronary and/or peripheral angiography and/or angio- 
plasty. were randomly assigned to receive 0.45% saline intravenously and acetylcisteine 
(600 mg orally twice daily) (Group A; n= 55) or 0.45% saline intravenously and acetyl- 
cisteine (1200 mg orally twice daily) (Group B; n=61) before and after a non-ionic, low- 
osmolality contrast dye administration. 
Resuns. Baseline creatinine concentration was similar (1.9+0.8 mg/dL in Group A vs. 
1.9iO.5 mgldL in Group 8, p= 0.57). The amount of contrast dye administered was simi- 
lar (Group A: 189t130 mLvs. Group 8: 158i78 mL, p= 0.14). Increase of at least 25% of 
the baseline value in the serum creatinine concentration 48h after the procedure 
occurred in 7155 patients in Group A (12.5%) and i/81 patients in Group B (1.8%) (p = 
0.028; OR = 0.14; 95% Cl = 0.01-0.98). By a two way repeated measures ANOVA. there 
was a statistical significant interaction between the changes of serum creatinine concen- 
tration from baseline and the treatment strategy (F = 8.46, p = 0.012). 
Conclusions: High dose of acetylcysteine plus hydration seems to be more effective than 
low dose and hydration in preventing contrast-dye-induced nephrotoxicity. 
1101-174 A Rapid Protocol for the Prevention of Contrast- 
Induced Renal Dysfunction (RAPPID Study) 
Christooher S. Baker, Andrew Wragg, Sanjay Kumar, Rodney De Silva. Roger J. Hall, 
Lawrence R. Baker, Charles J. Knight, Barts and the London NHS Trust, London, United 
Kingdom, The Hammersmith Hospitals NHS Trust, London, United Kingdom 
Background: Radiocontrast-induced nephropathy (RCIN) is a common complication of 
coronary angiography in patients with renal dysfunction (RD). Pre-treatment with oral N- 
acetylcysteine (NAC) has recently been shown to provide better prophylaxis against 
RCIN than IV hydration alone. Unfortunately, both protocols preclude prophylaxis of 
same day or emergency cases due to the need for prolonged pre-treatment. We per- 
formed the present study to test the hypothesis that a rapid protocol of IV NAC would 
prevent RCIN in patients undergoing cardiac catheterisationfintervention. Methods: We 
prospectively randomized 80 patients with stable, chronic RD, undergoing cardiac cathe- 
terisationlintervention at 3 centres in the UK, to a rapid protocol of IV NAC (150mg/Kg in 
500ml N/saline over 30 minutes immediately prior to contrast exposure followed by 
50mg/Kg in 500ml N/saline over 4 hours, N=41, 87 f 10 years, 90% male) or IV hydration 
(iml/Kg/hr for 12 hours pre and post contrast, N=39, 71 f 6.6 years, 85% male). Serum 
creatinine (SCr) was measured at baseline, 46 hours and 4 days after contrast exposure. 
RCIN was defined as an increase of at least O.Bmg/dL (44pmollL) or 25% above the 
baseline. Results: RCIN occurred in 2 of the 41 patients in the NAC group (5%) and in 6 
of the 39 patients in the hydration group (21%; PzO.045; relative risk: 2.8; 95% confi- 
dence intervals: 0.8 to 9.6). The volume of VisipaqueTM (a non-ionic, isotonic contrast 
agent) was 219 * 184 (NAC group) vs. 238 * 157 mL (hydration group) P=O.6. In the 
NAC group mean SCrfellfrom 1.65 * 0.59 to 1.77 + 0.74 48 hours and 1.79 f 0.72 mg/ 
dL 4 days post contrast (P=O.O2 and 0.023 vs. baseline respectively). In the hydration 
group SCr tended to increase from 1.75 * 0.42 to 1.81 f 0.8 and 1.8 * 0.51 mg/dL 
(P=O.99 and 0.23 respectively). NAC infusion was ceased after the bolus in 3 patients 
(7%) due to flushing, itching or a transient rash. Conclusion: This study demonstrates 
that in patients with RD undergoing coronary angiographylintewention, a rapid protocol 
of IV NAC reduces the incidence of RCIN and lowers SCr. Administration of IV NAC 
should be considered in all patients at risk of RCIN prior to contrast exposure when time 
restraints preclude adequate oral prophylaxis. 
1101-201 Reversal of Slow or No-Reflow During Percutaneous 
Tranluminal Coronary Angioplasty Using Boluses of 
lntracoronary Adenosine and Sodium Nitroprusside in 
Combination 
Kevur H. Parikh, Milan C. Chag. Urmil G. Shah, Hemang A. Baxi, Anish H. Chandarana, 
Ajay M. Naik, Kanan J. Shah, Ramesh K. Goyal. Sterling Hospital, Ahmedabad, India. L. 
M. College of Pharmacy, Ahmedabad, India 
Backgrounct Percutaneous intervention in Acute Coronary Syndrome (ACS) has been 
associated with high incidences of ?slow or no-reflow’, ranging from 11% to 30% with an 
increased risk of complications. The objectwe of the study was to evaluate the efficacy of 
